The demand is being driven by three forces at the same time: rising obesity prevalence, stronger clinical evidence, and a new generation of therapies that deliver weight loss outcomes previously difficult to achieve with medication alone
When your hunger is under control, youre less likely to consume excess calories, which often leads to fat accumulation around your abdomen
This will make adoption among the obese and diabetes patients easier and help reduce the cost of the drug by more than 90% within three-four years from about Rs 17,000-26,000 a month at present, depending on the dosage strength, as per analysts
If youre currently taking a GLP-1 medication (or are considering it) here are a few important tips: Talk to your doctor about any history of eye disease, especially diabetic retinopathy or glaucoma
10.1371/journal.pone.0113679 25 CarrizzoA.IzzoC.OlivetiM.AlfanoA.VirtuosoN.CapunzoM.et al (2018)